```html

Yellowness of the Sclera in Newborns

What is Yellowness of the sclera in newborns?

The sclera is the white outer layer of the eye. When a newborn’s sclera takes on a yellow hue, the condition is most commonly referred to as neonatal jaundice. The yellow color results from an excess of bilirubin—a yellow pigment formed when red blood cells break down—in the bloodstream. In healthy newborns, bilirubin is processed by the liver and excreted in the stool, but an immature liver or other medical issues can cause bilirubin to accumulate, leading to visible discoloration of the skin and sclera.

While mild jaundice is very common and often harmless, the yellowing of the sclera can sometimes signal more serious underlying problems. Because the eyes are one of the first places where bilirubin shows up, careful observation of scleral color can help parents and clinicians detect issues early.

Common Causes

Below are the most frequent reasons a newborn’s sclera may appear yellow. Many of these causes overlap, and a single baby may have more than one contributing factor.

• Physiologic (normal) jaundice – occurs in >60 % of term infants due to the newborn’s immature liver enzyme system.
• Breast‑milk jaundice – persistent jaundice that develops after the first week, linked to substances in breast milk that interfere with bilirubin processing.
• Breast‑feeding insufficiency – inadequate milk intake leads to dehydration and reduced bilirubin elimination.
• Hemolytic disease of the newborn (HDN) – maternal antibodies (e.g., Rh or ABO incompatibility) cause rapid red‑cell breakdown.
• Blood group incompatibility (ABO or Rh) – similar mechanism to HDN, often milder but still increases bilirubin load.
• Genetic enzyme disorders – e.g., G6PD deficiency, Crigler‑Najjar syndrome, or Gilbert’s syndrome, which impair bilirubin conjugation.
• Sepsis or infection – systemic infection can disrupt liver function and increase bilirubin production.
• Congenital liver anomalies – biliary atresia, choledochal cysts, or hepatic hypoplasia hinder bilirubin excretion.
• Perinatal asphyxia – lack of oxygen at birth damages liver cells, reducing bilirubin clearance.
• Medication‑induced jaundice – certain drugs given to mother (e.g., sulfonamides) or infant (e.g., antibiotics) can cause hemolysis or hepatic toxicity.

Associated Symptoms

The presence of yellow sclera often comes with other clinical clues that help pinpoint the cause.

• Yellowing of the skin, first on the face and then spreading to the chest, abdomen, and limbs.
• Lethargy or decreased feeding activity.
• High‑pitched crying or irritability.
• Dark (tea‑colored) urine and pale, clay‑colored stools.
• Rapid heart rate (tachycardia) or breathing difficulties.
• Enlarged liver or spleen on physical exam.
• Signs of hemolysis: pallor, low hemoglobin, or bruising.
• Fever, poor temperature regulation, or rash (suggesting infection).

When to See a Doctor

Newborn jaundice can progress quickly. Contact a pediatrician or seek urgent care if any of the following occur:

• The yellow color appears within the first 24 hours of life (early onset).
• The bilirubin level (as measured by a blood test) is rising rapidly or exceeds the age‑specific treatment threshold (see “Diagnosis”).
• The baby is feeding poorly, is unusually sleepy, or cannot wake for feeds.
• There is a fever > 38 °C (100.4 °F) or signs of infection.
• The baby’s skin looks gray or bluish instead of yellow, indicating possible oxygen deprivation.
• The yellowing spreads to the abdomen or limbs before the first 48 hours.
• There is a history of blood‑type incompatibility, G6PD deficiency, or previous sibling with severe jaundice.
• Any signs of bleeding, bruising, or an enlarged abdomen.

Diagnosis

Evaluation combines a careful visual exam with laboratory and imaging studies.

1. Visual assessment

Clinicians grade jaundice using the “Kramer rule” or a transcutaneous bilirubinometer, which measures skin reflectance.

2. Serum bilirubin testing

A heel‑stick blood sample yields total serum bilirubin (TSB). The result is plotted on an age‑specific nomogram (the Bhutani chart) to decide if treatment is needed.

3. Complete blood count (CBC) and reticulocyte count

Helps identify hemolysis or anemia.

4. Blood type and Coombs test

Detects ABO or Rh incompatibility.

5. Liver function panel

Assesses ALT, AST, alkaline phosphatase, and GGT to rule out intrinsic liver disease.

6. G6PD screening

Important in populations with high prevalence of the deficiency.

7. Abdominal ultrasound

Used when biliary atresia or structural liver disease is suspected; looks for an absent gallbladder or abnormal bile ducts.

8. Urine analysis

Detects hematuria or infection that could exacerbate jaundice.

Treatment Options

The goal is to keep bilirubin below neurotoxic levels and treat any underlying cause.

Phototherapy

• Standard of care for most cases with moderate to high bilirubin.
• Blue‑green light (460‑490 nm) converts bilirubin into water‑soluble isomers that are excreted without liver conjugation.
• Typically administered in an intensive‑care or nursery setting; home phototherapy units are available for selected low‑risk infants.

Exchange Transfusion

• Reserved for severe hyperbilirubinemia (TSB > 20 mg/dL in term infants or lower thresholds in preterm) or when phototherapy fails.
• Blood is gradually replaced to remove bilirubin‑laden red cells.

Intravenous Immunoglobulin (IVIG)

Used for immune‑mediated hemolysis (e.g., Rh incompatibility) to reduce antibody‑mediated red‑cell destruction.

Enhanced Feeding

• Frequent breastfeeding (8–12 times per day) promotes stool output and bilirubin elimination.
• If intake remains insufficient, supplement with expressed breast milk or formula.

Medications

• Phenobarbital may be prescribed for chronic conditions like Crigler‑Najjar type II to induce hepatic enzymes.
• Antibiotics for underlying sepsis.

Home Care Measures

• Ensure the infant is feeding well; track wet diapers (≥ 6 per day) and stools (≥ 3 per day in the first week).
• Maintain a warm but not overheated environment (room temperature 22‑24 °C).
• Keep skin exposed to indirect sunlight for short periods (10‑15 min) only if advised by a physician; direct sun can damage newborn eyes.

Prevention Tips

While physiologic jaundice cannot be eliminated, several steps lower the risk of severe yellowing:

• Early and frequent feeding – initiate breastfeeding within the first hour of life and continue on-demand.
• Monitor weight loss – newborns should lose < 10 % of birth weight in the first 5‑7 days; greater loss warrants evaluation.
• Maternal prenatal care – screen for blood‑type incompatibilities and G6PD deficiency.
• Delay of elective early discharge – observe newborns for at least 48 hours when risk factors exist.
• Avoid medications known to cause hemolysis (e.g., sulfonamides) in mothers and newborns unless absolutely necessary.
• Educate parents on how to recognize early yellowing and feeding problems.
• Vitamin K administration – standard at birth; deficiency can increase risk of bleeding that may worsen hemolysis.

Emergency Warning Signs

Key Take‑aways

Yellow sclera in newborns is most often a benign sign of physiologic jaundice, but it can also herald serious conditions that require prompt treatment. Early detection, diligent feeding, and timely laboratory evaluation are essential. Parents should feel empowered to monitor their baby’s feeding patterns and color changes, and they should never hesitate to seek medical care when warning signs appear.

References:

• Mayo Clinic. “Newborn jaundice.” https://www.mayoclinic.org
• American Academy of Pediatrics. “Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.” Pediatrics, 2022.
• National Institute of Health (NIH). “Bilirubin metabolism.” NCBI Bookshelf
• Cleveland Clinic. “Neonatal Jaundice.” https://my.clevelandclinic.org
• World Health Organization. “Guidelines for the Management of Neonatal Jaundice.” WHO Press, 2023.

```